Could not find the file: /1385/1/Oncology Fact Sheet Nr.99.pdf
The file you are trying to access may be related to this item:
Rothschedl, E. and Wolf, S. (2022): Pembrolizumab (Keytruda®) as monotherapy for the adjuvant treatment of adults and adolescents aged 12 years and older with stage IIB, IIC or III melanoma who have undergone complete resection. Update October 2022. Oncology Fact Sheet Nr. 99.
If you reached this page by following a link within the repository, please contact the Repository of AIHTA GmbH administration. Otherwise, please check that you have typed the URL in correctly, or contact the person or site that supplied you with this URL.